Transgenic Dendra2::tau expression allows in vivo monitoring of tau proteostasis in Caenorhabditis elegans
Disease Models & Mechanisms · 01.03.2024 · 17 (3)
DOI: 10.1242/dmm.050473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 28.03.2024. Verfasst von Marina Han und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Neuroscience, University of Washington, Seattle, WA 98195, USA. Hauptthemen laut MEDLINE: Caenorhabditis elegans Proteins, Proteostasis, tau Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, BLRD VA.
Abstract (Originalsprache)
Protein homeostasis is perturbed in aging-related neurodegenerative diseases called tauopathies, which are pathologically characterized by aggregation of the microtubule-associated protein tau (encoded by the human MAPT gene). Transgenic Caenorhabditis elegans serve as a powerful model organism to study tauopathy disease mechanisms, but moderating transgenic expression level has proven problematic. To study neuronal tau proteostasis, we generated a suite of transgenic strains expressing low, medium or high levels of Dendra2::tau fusion proteins by comparing integrated multicopy transgene arrays with single-copy safe-harbor locus strains generated by recombinase-mediated cassette exchange. Multicopy Dendra2::tau strains exhibited expression level-dependent neuronal dysfunction that was modifiable by known genetic suppressors or an enhancer of tauopathy. Single-copy Dendra2::tau strains lacked distinguishable phenotypes on their own but enabled detection of enhancer-driven neuronal dysfunction. We used multicopy Dendra2::tau strains in optical pulse-chase experiments measuring tau turnover in vivo and found that Dendra2::tau turned over faster than the relatively stable Dendra2. Furthermore, Dendra2::tau turnover was dependent on the protein expression level and independent of co-expression with human TDP-43 (officially known as TARDBP), an aggregating protein interacting with pathological tau. We present Dendra2::tau transgenic C. elegans as a novel tool for investigating molecular mechanisms of tau proteostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Neuroscience, University of Washington, Seattle, WA 98195, USA.
- Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, WA 98104, USA.
- Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA.
- Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA 98195, USA.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
ORCID-Profile: Brian C Kraemer
Förderung
- NIA NIH HHS
- NIH HHS
- BLRD VA
- NIDDK NIH HHS
- NINDS NIH HHS
- U.S. Department of Veterans Affairs
- National Institutes of Health
- BrightFocus Foundation
Zitieren
APA
Han, M., Saxton, A., Currey, H., Waldherr, S. M., Liachko, N. F., & Kraemer, B. C. (2024). Transgenic Dendra2::tau expression allows in vivo monitoring of tau proteostasis in Caenorhabditis elegans. Disease Models & Mechanisms, 17(3). https://doi.org/10.1242/dmm.050473
Vancouver
Han M, Saxton A, Currey H, Waldherr SM, Liachko NF, Kraemer BC. Transgenic Dendra2::tau expression allows in vivo monitoring of tau proteostasis in Caenorhabditis elegans. Disease Models & Mechanisms. 2024;17(3). doi:10.1242/dmm.050473
BibTeX
@article{Han2024,
author = {Han, Marina and Saxton, Aleen and Currey, Heather and Waldherr, Sarah M and Liachko, Nicole F and Kraemer, Brian C},
title = {Transgenic Dendra2::tau expression allows in vivo monitoring of tau proteostasis in Caenorhabditis elegans},
journal = {Disease Models & Mechanisms},
year = {2024},
volume = {17},
number = {3},
doi = {10.1242/dmm.050473}
}
EUVIMED